Related Experiment Videos
[Cystine lithiasis and extracorporeal lithotripsy].
Annales D'Urologie
|January 1, 1989
Summary
Extracorporeal shock wave lithotripsy (ESWL) effectively fragments cystine stones, but achieving a stone-free status requires further optimization. Adjuvant dissolving drugs may improve outcomes for patients with difficult-to-treat cystine stones.
Area of Science:
- Urology
- Nephrology
- Biomedical Engineering
Background:
- Cystine stone disease presents a therapeutic challenge, especially for patients with recurrent stone formation or prior surgical interventions.
- Extracorporeal shock wave lithotripsy (ESWL) using the HM3 Dornier lithotriptor offers a novel approach for managing these complex cases.
Observation:
- Three patient cases demonstrated satisfactory fragmentation of cystine stones with ESWL.
- However, the rate of complete stone clearance (stone-free status) was notably lower than desired.
Findings:
- A European multicenter study involving 61 cases corroborated these observations, reporting a 90% fragmentation rate but only a 30% stone-free rate for kidney stones and 77% for ureteral stones.
- These findings highlight ESWL's efficacy in breaking down cystine calculi but underscore limitations in achieving complete eradication.
Implications:
- Adjuvant therapy with dissolving drugs may enhance the stone-free rate following ESWL for cystine stones.
- Further research into combination therapies is warranted to optimize treatment outcomes for patients with cystinuria.